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ABSTRACT
Background. Thirty-day mortality after surgery for colo-
rectal cancer may vastly underestimate 1-year mortality.
This study aimed to quantify the excess mortality in the
first postoperative year of stage I–III colorectal cancer
patients and to identify risk factors for excess mortality.
Methods. All 2,131 patients who were operated with
curative intent for stage I–III colorectal cancer in the
western region of the Netherlands between January 1,
2006, and December 31, 2008, were analyzed. Thirty-day
mortality and relative survival were calculated. In addition,
relative excess risk (RER) of death was estimated by a
multivariable model.
Results. Thirty-day mortality was 4.9%. One-year mor-
tality was 12.4%. Risk factors for excess mortality in the
first postoperative year for colon cancer patients were
emergency surgery (excess mortality 29.7%, RER 2.5, 95%
confidence interval 2.5–5.0), a Charlson score of [1
(excess mortality 12.6%, RER 2.3, 95% confidence interval
1.5–3.7), stage II or III disease (excess mortality 14.9%,
RER 3.9, 95% confidence interval 1.9–8.1), and postoper-
ative adverse events (excess mortality 22.6%, RER 2.1,
95% confidence interval 1.4–3.2).
Conclusions. The 30-day mortality rate highly underesti-
mates the risk of dying in the first year after surgery, with
excess 1-year mortality rates varying from 15 to 30%. This
excess mortality was especially prominent in patients with
comorbidities, higher stages of disease, emergency surgery,
and postoperative surgical complications.
Adverse postoperative events are most often recorded as
30-day mortality and postoperative complications. Large
studies show that colorectal cancer surgery can be con-
sidered as high risk, with reported postoperative mortality
and complication rates of approximately 5% and 20–40%,
respectively.1–4
For the prognosis of colorectal cancer patients who
undergo curative surgery, adverse postoperative events are a
determining factor. Several studies showed that complica-
tions are of prognostic importance because they can cause
delayed mortality.5,6 Furthermore, specific complications,
such as anastomotic leaks, are associated with local recur-
rences and reduced survival.7–9 Elderly patients with severe
comorbidities, lower socioeconomic status, stage III tumor,
or preoperative tumor complications have been demonstrated
to be at higher risk for postoperative adverse events.10–12
Earlier studies have shown that 30-day mortality after
surgery for colorectal cancer vastly underestimates 1-year
mortality, even in young colorectal cancer patients who
were operated with curative intent.13,14 Furthermore,
Dekker et al. showed that 1-year excess mortality (1-year
mortality adjusted for expected mortality in the general
population) was the main determining factor for age-
related survival differences: after surviving the first year,
elderly patients had the same cancer-related survival as
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younger patients.14 This suggests that there may be a
prolonged effect of the assault of surgery. To date, there is
little information on the etiology of the excess mortality in
the first postoperative year. Because of the lack of reported
determinants of excess mortality in the contemporary lit-
erature, we set out to determine the role of comorbidity,
emergency surgery, and postoperative complications,
expecting that these factors are main determinants for
1-year excess mortality, especially in elderly patients,
where the incidence of comorbidity is higher and emer-
gency surgery and postoperative complications occur more
frequently. The identification of risk factors would help to
stratify patients according to their risk. Moreover, risk
factors may be modifiable and targeted optimization of care
may result in an improved prognosis.
Therefore, the first aim of this study was to quantify the
excess mortality in the first postoperative year of stage I–III
colorectal cancer patients operated with curative intent
according to several patient and tumor characteristics. The
second aim of this study was to identify risk factors for
excess mortality in the first postoperative year.
METHODS
Data
In the Netherlands, all newly diagnosed malignancies
are registered in the nationwide population based Nether-
lands Cancer Registry. The Leiden Cancer Registry, part of
the Netherlands Cancer Registry, collects data on all cancer
patients diagnosed in one of the nine affiliated hospitals in
the midwestern part of the Netherlands. This region com-
prises one university hospital, six teaching hospitals, and
two nonteaching hospitals, and serves a population of 1.7
million inhabitants.
Independently trained data managers collected data from
the original patient files after receiving an automatic report
from the Dutch pathology reporting system, PALGA.
Information on patient characteristics, tumor characteris-
tics, treatment, hospital of diagnosis, and/or treatment and
follow-up were recorded. Tumor site and morphology were
coded according to the International Classification of Dis-
eases for Oncology.15 Cancers were staged according to the
tumor, node, metastasis system classification for malignant
tumors, 6th edition.16 The quality of the data was high, and
completeness was estimated to be at least 95%.17,18
In 2006, a regional audit for colorectal cancer surgery
(KIC) was started in the nine affiliated hospitals of the
Leiden Cancer Registry. The data collection was extended
to data that reflected quality of care and case-mix factors.
These prospectively collected data were used for bench-
marking and feedback on each hospital’s process,
ultimately to improve the quality of care in the entire
region. Data were collected on patient demographics (age,
sex, comorbidities, socioeconomic status), tumor charac-
teristics (localization, tumor, node, metastasis system
staging), and treatment characteristics (neoadjuvant or
adjuvant treatment, type of surgery, emergency, hospital of
treatment, surgical complications, length of stay). Apart
from American Society of Anesthesiology (ASA) scores,
completeness of data was more than 98%.
Patients
All patients who had a resection of stage I, II, or III tumor
of the colon (C18), the rectosigmoid (C19), or the rectum
(C20) from January 1, 2006, to December 31, 2008, in one of
the affiliated hospitals were identified. Excluded were
patients with stage IV tumor, patients with a tumor of the
appendix, and patients who did not undergo tumor resection.
Age was categorized as younger than 65 years, 65–74 years,
and 75 years and older. Comorbidity was recorded according
to a slightly modified version of the Charlson index used by
the Dutch Cancer Registry. ASA scores were categorized as
ASA I and II, or ASA III and IV. Missing data from the ASA
score were included as a separate category. Socioeconomic
status was categorized as low, intermediate, and high on the
basis of area-based data concerning income, employment,
and education provided by the Netherlands Institute for
Social Research.19 Surgical complications comprised
superficial wound infections, abdominal wall problems (i.e.,
dehiscence), deep infections, and intra-abdominal compli-
cations, including bleeding, ileus, abscess, or anastomotic
leaks. As a substitute for overall complications (both surgical
and nonsurgical, such as pulmonary or cardiac events), a
prolonged length of stay was used, which was defined as a
hospital admission of 15 days or longer after surgery. Vital
status of all patients was obtained actively on a regular basis
through linkage of the cancer registry data with the inte-
grated database of the municipal registry and the central
bureau for genealogy. Follow-up was completed until
January 1, 2010.
Statistical Analysis
All analyses were performed for colon and rectum
cancer patients separately. Stratified by several character-
istics, 30-day mortality, 1-year overall mortality (all
causes), and 1-year excess mortality rates were calculated.
Excess mortality was calculated by the following formula:
[(Observed number of deaths in the first year - Expected
number of deaths in the matched general population)/
Number of patients]. The expected number of deaths was
calculated by national life tables matched for age, sex, and
year of incidence. Survival curves of the relative survival
in the first year were constructed. Relative survival is the
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preferred way to describe the prognosis of elderly cancer
patients because it takes into account the risk of dying of
other causes than the disease of interest in the absence of
cause of death in the database. Relative survival was cal-
culated as the ratio of observed survival among the cancer
patients to expected survival. Relative excess risk (RER) of
death and P values were estimated by a multivariable
generalized linear model with a Poisson distribution based
on collapsed relative survival data based on exact survival
times.
RESULTS
From January 1, 2006, to December 31, 2008, a total of
2131 patients had a colorectal resection in one of the nine
affiliated hospitals for stage I–III colorectal cancer; 1407
underwent treatment for colon cancer and 724 for rectal
cancer. Table 1 lists the characteristics of the study popu-
lation for colon and rectal cancer patients. Colon patients
were older, more often female, had more comorbidity, and
more often required emergency surgery.
Mortality
The overall observed 30-day mortality was 4.9%, and
1-year mortality was 12.4%. Median follow-up time was
24.6 (range 0.03–47.9) months. All patients had follow-up
for at least 1 year unless they died before then. Table 2
shows crude overall mortality and excess mortality rates of
stage I–III colon and rectal cancer patients in the first year
after surgery according to several characteristics. The
observed 1-year mortality rates of patients older than 75
were 21 and 16% for colon and rectal patients, respec-
tively. High excess mortality rates were observed in colon
cancer patients with ASA III/IV (19.9%), a stage III tumor
(14.9%), and a Charlson score of 2 or higher (17.5%), and
in patients with postoperative surgical complications
(22.6%) or a prolonged length of stay (22%). Of all colon
cancer patients with an emergency resection, 33% died in
the first year, an excess mortality of 30%. In rectal cancer
patients, high excess mortality rates were observed in
elderly patients (8.9%), patients with a Charlson score of 2
or higher (13%), and patients with postoperative compli-
cations (11.2%). Figure 1 shows relative survival curves of
all patients in the cohort (Fig. 1a) and an example of rel-
ative survival in a specific subgroup: colon cancer patients
treated in an emergency setting (Fig. 1b).
Risk Factors for Excess Mortality in the First Year
Figure 2 shows all identified risk factors for 1-year
mortality for colon and rectal cancer patients separately.
The effect is represented as adjusted RER for 1-year
mortality. In Supplementary Table, the results of univariate
and multivariable analyses for risk factors for excess
mortality in the first year are shown.
For colon cancer patients, significant risk factors for
excess mortality in the first year after surgery were a stage
III tumor [RER 2.6, 95% confidence interval (CI) 1.3–5.3,
P \ 0.001], a Charlson score of[1 (RER 2.5, 95% CI 1.6–
4.0, P = 0.001), an emergency resection (RER 3.3, 95% CI
2.5–5.), P \ 0.001), and postoperative surgical complica-
tions (RER 2.1, 95% CI 1.4–3.3, P \ 0.001). Particular
comorbidities that increase the risk of excess mortality






\65 371 (26.4%) 264 (36.5%)
65–74 390 (27.7%) 236 (32.6%)
C75 646 (45.9%) 244 (30.9%)
Sex
Male 672 (47.8%) 406 (56.1%)
Female 735 (52.2%) 318 (43.9%)
Stage
I 234 (16.6%) 214 (29.6%)
II 661 (47.0%) 231 (31.9%)
III 512 (36.4%) 279 (38.5%)
Emergency
Emergent 188 (13.4%) 17 (2.4%)
Elective 1219 (86.6%) 707 (97.6%)
ASA
I/II 633 (45.0%) 411 (56.8%)
III/IV/V 297 (21.1%) 123 (17.0%)
Unknown 477 (33.9%) 190 (26.2%)
Charlson
0 757 (53.8%) 444 (61.3%)
1 358 (25.4%) 160 (22.1%)
2 or more 292 (20.8%) 120 (16.6%)
Complications
No 1155 (82.1%) 559 (77.2%)
Yes 252 (17.9%) 165 (22.8%)
Hospital stay
\15 days 956 (67.9%) 471 (65.0%)
C15 days 419 (29.8%) 238 (32.9%)
Unknown 32 (2.3%) 15 (2.1%)
Socioeconomic status
High 449 (31.9%) 243 (33.6%)
Intermediate 480 (34.1%) 241 (33.3%)
Low 478 (34.0%) 240 (33.1%)
ASA American Society of Anesthesiology
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were a previous tumor (RER 1.8, 95% CI 1.2–2.8,
P = 0.009), pulmonary disease (RER 2.1, 95% CI 1.3–3.2,
P = 0.001), gastrointestinal disease (RER 2.0, 95% CI
1.1–3.6, P = 0.02), and neurologic disease (RER 1.7, 95%
CI 1.0–2.8, P = 0.04).
For rectal cancer patients risk factors for excess mor-
tality in the first year, were age C75 years (RER 7.0, 95%
CI 1.8–27.4, P = 0.009), Charlson score of [1 (RER 5.2,
95% CI 1.7–15.9, P = 0.01), and postoperative surgical
complications (RER 5.9, 95% CI 1.3–26.8, P = 0.02).














Overall 6.3 14.8 10.9 2.4 7.9 4.8
Sex
Male 7.7* 16.2 12.1 3.5* 9.6 6.2
Female 4.9* 13.5 9.8 0.9* 5.7 3.2
Age
\65 1.6* 5.9* 5.3* 0.4* 2.3* 1.6*
65–74 4.1* 12.3* 10.2* 0.4* 6.8* 4.5*
C75 10.2* 21.4* 14.6* 6.7* 15.6* 8.9*
Socioeconomic status
High 4.7* 12.9 9.0 2.5 7.0 3.5
Intermediate 8.5* 15.2 11.5 2.9 9.1 6.7
Low 5.4* 16.1 12.1 1.7 7.5 4.2
ASA
I/II 1.9* 7.9* 4.4* 1.0* 5.1* 2.3*
III/IV 11.1* 24.9* 19.9* 6.5* 14.6* 10.2*
Unknown 9.0* 17.6* 13.8* 2.6* 9.5* 6.6*
Stage
I 6.8 9.8* 6.1* 1.9 4.7 1.3
II 5.9 13.8* 9.5* 3.0 8.2 5.4
III 6.5 18.4* 14.9* 2.2 10.0 7.1
Emergency
Emergent 18.1* 32.9* 29.7* NA
Elective 4.4* 11.9* 8.0*
Comorbidity
No 4.3* 10.5* 7.7* 0.3* 4.4* 1.7*
Yes 7.7* 17.8* 13.2* 4.5* 11.5* 8.0*
Charlson
0 4.1* 10.8* 7.5* 0.7* 4.7* 1.8*
1 6.7* 17.0* 12.6* 3.8* 10.0* 6.9*
2 or more 11.3* 22.3* 17.5* 6.7* 16.7* 13.0*
Complications
No 5.2* 12.4* 8.3* 1.4* 6.1* 2.9*
Yes 11.1* 25.8* 22.6* 5.5* 13.9* 11.2*
Hospital stay
\15 days 5.4 9.8* 6.2* 2.3 5.5* 3.0*
C15 days 8.4 26.5* 22.0* 2.5 11.3* 7.2*
Unknown 3.1 9.4* 5.0* 0 26.7* 24.3*
ASA American Society of Anesthesiology
* P \ 0.05 for the different value within a variable
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Particular comorbidities that increased the risk were
hypertension (RER 2.4, 95% CI 1.1–5.5, P = 0.04), vas-
cular disease (RER 3.4, 95% CI 1.3–9.3, P = 0.02), kidney
disease (RER 7.9, 95% CI 2.4–26.5, P = 0.001), and
neurologic disease (RER 3.3, 95% CI 1.0–10.4, P = 0.04).
DISCUSSION
The excess mortality in the first year after surgery for
stage I–III colorectal cancer is high. Overall, 12.4% of all
patients died within the first year, compared to a 4.9% 30-
day mortality rate. Thus, the 30-day mortality rate greatly
underestimates the risk of dying in the first year after
surgery. After adjustment for expected mortality in the
general population, patients with comorbidities, patients
with stage III tumors, patients requiring emergency resec-
tion, and patients with postoperative surgical complications
were at higher risk for excess mortality, with excess 1-year
mortality rates varying from 15 to 30%.
To our knowledge, the present study is the first detailed
population-based study to quantify excess mortality after
colorectal cancer surgery with curative intent and to
examine risk factors for excess mortality within the first
year. Clinical, accurate data of the Netherlands Cancer
Registry were used, and variables not only comprised age
and stage, but also data on comorbidities and emergency
and postoperative complications. Moreover, relative sur-
vival and excess mortality rates were used as outcome
measures. This also takes into account mortality not
attributable to the examined disease or the treatment of the
disease.
The results in this study should be interpreted with
regard to several limitations inherent to its observational
design. In the univariate and multivariable analyses,
potential confounders were examined and added to the
model (Supplementary Table). In calculations of expected
mortality, patients with severe comorbidity may not match
well with the general population. This could have led to a
slight underestimation of the expected mortality in this
group, resulting in a lower excess mortality.
Furthermore, only data on postoperative surgical com-
plications were available. To estimate the impact of both
surgical and nonsurgical complications (e.g., pneumonia,
delirium, cardiac event, urinary tract infection), a pro-
longed length of stay was used as a substitute of
postoperative complications in general. In this study, a
a bFIG. 1 Relative survival in the
first year. a All patients.
b Colon cancer patients treated
in an emergency setting. The
horizontal dotted line marks day
30 day after surgery. The blue
line indicates the relative
survival in the first year. The
space between the vertical
dotted line and the blue line
represents the excess mortality
after 30 days and within the first
year after surgery
FIG. 2 Factors associated with
1-year relative survival in
multivariable analysis for colon
and rectal cancer patients. At
the y axis, the effect size is
represented as adjusted relative
excess risk (RER) for 1-year
mortality, compared to the
reference group, which always
has a RER of 1
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prolonged length of stay was defined as a stay of 15 days or
longer. An uneventful postoperative period is unlikely to
result in a longer hospital stay, and therefore, it can func-
tion as a proxy for overall complications. This assumption
is in line with a study of Cohen et al., who demonstrated a
mean length of stay after colorectal surgery of 16 days in
the presence of complications, versus 6 days when no
complications occurred.20 In the present study, a prolonged
length of stay occurred in 30.4% of the patients. This is
also consistent with findings in the literature.20,21
Despite these limitations, the present study provides
valuable information, showing that 30-day mortality und-
erreports postoperative mortality after colorectal surgery.
This is consistent with previous studies.13,14 Visser et al.
reported a doubling of 30-day mortality to 9.1% at 90 days
after surgery.13 A previous study from our group showed
that 1-year excess mortality was the main determinant for
age-related survival differences.14 In the present data, the
steepest decline in relative survival was observed during
the first 7–11 months after surgery. The excess mortality
was especially high in patients with comorbidities, stage III
disease, emergency surgery, postoperative surgical com-
plications, and a prolonged length of stay. These risk
factors have been previously described as risk factors for
postoperative mortality and survival.11,12,22,23 However,
these reports did not adjust for expected mortality in the
general population, thereby not taking into account the risk
of dying of other causes than colorectal cancer.
The aim of identifying risk factors for 1-year excess
mortality was to find targets for improvement of patient
care. However, these risk factors may not be easily
malleable.
Comorbidity
The prevalence of comorbid disease is increasing with
the aging population and improvements in modern medi-
cine.24,25 Patients with comorbidity may have less biologic
reserve, and comorbidities alter organ functions.26 More
research is needed on these mechanisms and the influence
of comorbidities on postoperative outcomes. Obviously,
optimizing perioperative care to reduce surgical risk by
thorough preoperative assessment and by additional sup-
portive measures may improve the prognosis of patients. A
multidisciplinary approach with integrated chronic disease
management in cancer patients in the posthospital period
also seems warranted.
Stage III Disease
Patients with stage III disease had an increased risk of
excess 1-year mortality. This could be due to cancer
recurrences, although it is unlikely a large part of early
mortality is due to cancer recurrences in patients operated
with curative intent. An earlier study on relapses in these
patients showed that only a small number of patients
experienced a recurrence within the first year. Furthermore,
only 10% of patients with a recurrence die within 1 year.27
Emergency Surgery
Emergency surgery has consistently been demonstrated
to be a major risk factor for adverse outcome in colorectal
surgery. Efforts should be made to reduce the number of
patients in need of an emergent intervention. In this
respect, national screening programs could be helpful. If
colorectal cancer could be identified at an earlier (asymp-
tomatic) stage, it could be expected that the need for
emergent surgery may be reduced.
Postoperative Surgical Complications or a Prolonged
Length of Stay
Patients with postoperative surgical complications or a
prolonged length of stay had an increased risk for excess
mortality in the first year. These results compare to a recent
study by Greenblatt et al.5 They showed that readmission
after colectomy due to a postoperative complication was
predictive for 1-year mortality. Two studies by Ghaferi
et al. showed that differences in death after major com-
plications were the primary determinant of variation of
mortality between hospitals.28,29 This indicates that effec-
tive management of postoperative complications may
reduce postoperative mortality and improve patient out-
comes. This provides a potential target for improvement of
the quality of cancer care. Not only prevention of com-
plications but also early recognition and aggressive
treatment of complications can improve patient outcomes.
Identifying structures, processes, and best practices to
reduce the occurrence of complications and improve the
management of complications should have priority.
Although randomized, controlled trials are crucial for
determination of efficacious interventions, large cohort
studies and comparative effectiveness research are essen-
tial to fill critical gaps in defining optimal strategies for
complication management.30
CONCLUSIONS
In conclusion, the excess mortality in the first postop-
erative year after colorectal cancer surgery is high and
reflects postoperative risk more accurately than 30-day
mortality. The presence of comorbidities, stage III disease,
emergency resection, and postoperative surgical compli-
cations were predictive for excess mortality, with excess
1-year mortality rates as high as 15–30%. These risk
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factors may not be easily modifiable. Nevertheless, their
identification is important to develop tailored treatment of
high-risk patients. Moreover, identifying effective strate-
gies for both prevention and treatment of complications
could have the potential to improve patient outcomes.
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